Phase IB study of pembrolizumab (Pembro) and pegylated-interferon alfa-2b (Peg-IFN) in advanced melanoma (MEL).Diwakar Davar, Giuseppe Lo Russo, Joë-Marc Chauvin et al.|Journal of Clinical Oncology|2016Cited by 2